How Much Does GLOW Peptide Cost? 2026 Pricing

GLOW peptide blends — typically sold as a combined GHK-Cu / BPC-157 / TB-500 vial — run roughly $45 to $110 per 10 mg vial from research-material suppliers as of mid-2026, with most US-domiciled sellers landing between $58 and $85. Bulk tiers cut that meaningfully: 5-vial packs commonly price at $42–$65 per vial, and 10-vial kits at $35–$55. The spread is not arbitrary. It tracks whether the supplier pays for per-lot third-party HPLC and mass spec (roughly $180–$400 per assay, amortized across the batch), whether the peptide content is mass-verified or assumed, and how the vial is shipped and stored. A $28 vial and an $95 vial are not the same purchase decision.

What the price actually covers

A "GLOW" listing is a blend, not a single compound, and that matters for cost analysis. Three distinct peptide species share one vial, which means the analytical burden is roughly triple that of a single-peptide reference material. A correct certificate of analysis for a blend has to resolve and quantify each component separately.

Here is what sits inside a typical mid-market price:

Raw synthesis and peptide content. Crude synthesis of the constituent peptides at scale runs a few dollars per milligram at the kilo level, but net peptide content — the fraction that is actually peptide rather than residual water, acetate counter-ion, and salts — is commonly 75–88% by weight. A vial labeled "10 mg" that is 78% net peptide contains 7.8 mg of the material you are paying for. Suppliers who publish net peptide content by nitrogen analysis or amino acid analysis charge more, correctly.
HPLC purity assay. Reversed-phase HPLC at 214 nm is the standard identity/purity workhorse. A single third-party run costs $120–$250. For a three-component blend requiring baseline separation, expect a longer gradient — 35–60 minutes per sample injection versus 15–20 for a simple isocratic single-peptide check — and a correspondingly higher line item.
Mass spectrometry confirmation. ESI-MS or MALDI-TOF to confirm each species' molecular weight adds $150–$300 per lot. Without it, HPLC alone tells you a peak is pure; it does not tell you the peak is the right molecule.
Lyophilization, vialing, and stoppering. Sterile-filtered fill and lyophilization in a controlled environment adds roughly $3–$9 per vial at moderate volumes, more at small batch sizes.
Cold-chain handling. Insulated shipper plus gel packs runs $8–$22 per parcel; dry ice for longer transit adds $25–$60. Some suppliers bury this in the unit price, some line-item it at checkout. Read the shipping terms before comparing headline numbers.

Price bands you will actually encounter

| Tier | Per 10 mg vial | What you generally get |

|---|---|---|

| Sub-$35 | $18–$34 | Batch-level COA at best, often reused across lots; no MS; no net peptide content |

| Mid | $45–$75 | Per-lot HPLC, MS confirmation, lot number printed on the vial |

| Upper | $80–$120 | Per-lot third-party HPLC + MS, net peptide content stated, retained samples, stability data |

| Bulk / wholesale | $30–$55 | Same documentation as mid or upper tier, spread over 10–50 vials |

The upper tier's premium is $35–$50 per vial over mid. Whether that is worth paying depends entirely on whether your work requires the documentation, which is the part most cost comparisons skip. Our position on documentation standards is laid out under quality.

The cheapest vial in a comparison is often the most expensive one per usable data point, because a lot you cannot characterize is a lot you cannot cite.

When GLOW blends are the wrong purchase

This is the section that costs suppliers money, so most pages omit it. Name the failure modes plainly:

You need attributable single-variable data. A three-peptide blend has three simultaneously varying inputs. If your protocol design requires isolating the contribution of one species, a blend is analytically useless no matter how good the COA is. Buy the three components separately — that will cost more, typically $95–$150 total versus $60 for a blend, and it is the correct spend.
You are buying on price alone under $35/vial. At that price the arithmetic does not close. Per-lot third-party analysis on a blend costs $270–$550. A supplier selling at $28 with a claimed per-lot HPLC-and-MS package is either running very large batches (plausible at 5,000+ vials), reusing an old COA, or not testing. Ask for the lot number on the COA and confirm it matches the number on the vial. If they do not match, you have a batch-level document, not a lot-level one.
Your storage cannot hold −20 °C. Lyophilized peptide blends are typically rated 24–36 months at −20 °C, roughly 12–18 months at 4 °C, and considerably less at ambient. GHK-Cu in particular is a copper complex and behaves differently under thermal and oxidative stress than the linear peptides it is blended with. If your facility only has a 4 °C fridge, you are buying shelf life you will not get, and the effective cost per usable month climbs 40–60%.
You need documentation you cannot obtain retroactively. Retained-sample policies vary wildly. Some suppliers hold a retain for 12 months; many hold none. If a result looks anomalous 8 months out and there is no retain, you cannot re-assay the original material. That is a design flaw in the purchase, not a supplier failure — it was knowable at checkout.
You are ordering internationally without checking customs. Reference materials cross borders under classifications that vary by destination. Seizure rates on non-declared research chemical parcels are non-trivial, and a $70 vial lost in customs plus a $22 cold shipper is a $92 write-off with no recourse under most returns policies.
Blends are also harder to re-verify. If you send a vial to an independent lab for confirmation, expect $250–$450 for a three-component resolution versus $120–$200 for a single peptide. Independent verification of a blend costs more than the blend.

A further limitation worth stating: purity percentages on blends are frequently reported in a way that flatters the product. A COA reading "99.2%" on a blend may describe the combined peak area of the three intended species relative to total peak area, which says nothing about whether the ratio between them matches the label. A vial sold as 5 mg / 5 mg / 5 mg could be 8 / 4 / 3 and still show 99% "purity" by that definition. Ask for the individual component quantitation, not the aggregate number. Suppliers who cannot produce it are telling you something.

Cost per milligram, not cost per vial

Headline vial prices mislead because fill weights differ. Normalize before comparing:

A $58 vial at 10 mg labeled weight and 82% net peptide content = $7.07 per mg of actual peptide.
A $34 vial at 10 mg labeled weight with unstated net content — assume the low end, 72% — = $4.72 per mg, but with no documentation supporting the assumption.
A $95 vial at 15 mg and 88% verified content = $7.20 per mg, with a verified denominator.

The $34 vial looks 33% cheaper and may be. It may also be 60% net peptide, which puts it at $5.67 per mg with no way to know. The variance is the cost. Across a 12-month research program consuming 40 vials, a mid-tier supplier at $62 runs $2,480; the sub-$35 supplier runs $1,360. The $1,120 saved is real money — and it is a rational trade only if your work does not depend on lot-level attribution. If it does, one uncharacterizable lot forcing a repeat of a 6-week experiment erases the savings.

How to qualify a supplier before the second order

Treat the first order as an evaluation, not a supply relationship:

Request the COA before purchase, not after. A supplier who will not send it pre-sale will not send it post-sale either.
Check that the chromatogram is included as an image, not just a summary table. A table with a number is an assertion; a chromatogram with a visible baseline, retention times, and integration marks is evidence.
Confirm the analytical lab is named and independent. In-house HPLC is legitimate and common, but it is a different claim than third-party.
Match lot number: vial label → COA header → invoice. Three-way match or it is not traceable.
Ask what the retained sample policy is and get the answer in writing.
Order a single vial first. A $65 test purchase is cheap relative to a $2,400 annual commitment.

Broader supplier-evaluation criteria — the things that separate documented material from a listing with a stock photo — are covered in our quality research chemicals suppliers breakdown, and comparative notes across vendors sit in high purity peptides review.

Bulk economics and where the curve flattens

Volume discounts on blends follow a predictable shape. The first meaningful break is at 5 vials (typically 18–25% off single-unit), the second at 10 (30–38%), and a third around 25–50 units (42–50%). Past roughly 50 vials, the curve flattens hard — the marginal cost is now dominated by synthesis and fill, not by amortized analysis, so a 200-vial order rarely beats a 50-vial order by more than 6–8% per unit.

That flattening has a practical consequence: buying 200 vials to chase a 7% discount means holding 200 vials against a 24-month shelf life. If your consumption rate is 3 vials a month, 200 vials is a 66-month supply, and 42 months of it will expire unused. The correct order size is the one your freezer and your burn rate justify, which for most single-lab programs is 10–25 vials. Tiered pricing and account terms are documented on the wholesale page.

The honest summary

Budget $45–$85 per 10 mg vial for a GLOW blend with per-lot HPLC and mass spec documentation, $35–$55 at 10-vial volume, and treat anything under $35 as an undocumented material that may be perfectly fine and may not be — you will not be able to tell, and neither will a reviewer. Add $8–$60 per shipment for cold-chain and $250–$450 if you intend to independently verify a lot.

All materials described here are supplied strictly for laboratory research use and are not for human or veterinary use; see research use only. Questions about specific lot documentation go through contact.

Supplied strictly for in-vitro laboratory research by qualified researchers and institutions. Not a drug, food, cosmetic or dietary supplement. Not for human or veterinary consumption. Not evaluated by the FDA.